LVAD (left ventricular heart assist device) & bioengineering to drive Terumo
This article was originally published in Clinica
Executive Summary
In a recent interview with Clinica, Japanese company Terumo outlined its future growth strategy, which focuses on new technologies for treating cardiovascular disease.